Serine

Serine

SCHEMBL27152223

CCCC(=O)O.N[C@@H](CO)C(=O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR3 O14843 1/20 0.56
▸ HDAC3 O15379 1/20 0.56
▸ HDAC1 Q13547 1/20 0.56
▸ HDAC2 Q92769 1/20 0.56
▸ HDAC8 Q9BY41 1/20 0.56
▸ SLC1A1 P43005 6/20 0.52
▸ SLC1A2 P43004 5/20 0.52
▸ SLC1A3 P43003 4/20 0.52
▸ GRIK1 P39086 3/20 0.52
▸ GRIK2 Q13002 3/20 0.52
▸ GRM8 O00222 2/20 0.52
▸ GRM6 O15303 2/20 0.52
▸ GRM7 Q14831 2/20 0.52
▸ GRM4 Q14833 2/20 0.52
▸ GRIN2D O15399 1/20 0.52
▸ GRIN3B O60391 1/20 0.52
▸ GSR P00390 1/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ GRM5 P41594 1/20 0.52
▸ GRIA1 P42261 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Serine SCHEMBL2507758 1.00 FFAR3 (0.56) FFAR3HDAC3HDAC1HDAC2HDAC8
Succinic Acid SCHEMBL7991504 0.86 SLC1A1 (0.61) SLC1A1SLC1A2SLC1A3GRIK1GRIK2
Succinic Acid SCHEMBL7991499 0.86 SLC1A1 (0.61) SLC1A1SLC1A2SLC1A3GRIK1GRIK2
Butyric Acid SCHEMBL31699640 0.84 FFAR3 (0.59) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL17941814 0.84 FFAR3 (0.59) FFAR3HDAC3HDAC1HDAC2HDAC8
Dodecanoate SCHEMBL25310996 0.84 GPR84 (0.63) CYP1A2ALDH1A1ALOX15BLMKMT2A
Myristic Acid SCHEMBL27890892 0.84 GPR84 (0.63) CYP1A2ALDH1A1ALOX15BLMKMT2A
Palmitic Acid SCHEMBL28927197 0.84 GPR84 (0.63) CYP1A2ALDH1A1ALOX15BLMKMT2A
Octanoic Acid SCHEMBL26624656 0.84 GPR84 (0.63) CYP1A2ALDH1A1ALOX15BLMKMT2A
Decanoic Acid SCHEMBL13279587 0.84 GPR84 (0.63) CYP1A2ALDH1A1ALOX15BLMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240207213-A1 METHODS AND COMPOSITIONS FOR TREATING DISORDERS WITH ORAL SYSTEMICALLY BIOAVAILABLE BUTYRATE CONJUGATES THE UNIVERSITY OF CHICAGO 2024-06-27 — — US disclosed
EP-4326232-A1 METHODS AND COMPOSITIONS FOR TREATING DISORDERS WITH ORAL SYSTEMICALLY BIOAVAILABLE BUTYRATE CONJUGATES The University of Chicago (US) 2024-02-28 — — EP disclosed
WO-2022226482-A1 METHODS AND COMPOSITIONS FOR TREATING DISORDERS WITH ORAL SYSTEMICALLY BIOAVAILABLE BUTYRATE CONJUGATES THE UNIVERSITY OF CHICAGO (US) 2022-10-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240207213-A1 METHODS AND COMPOSITIONS FOR TREATING DISORDERS WITH ORAL SYSTEMICALLY BIOAVAILABLE BUTYRATE CONJUGATES HBB, SI, FABP2 FFAR3 31/4885HDAC3 486/4885HDAC1 933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback